Dr. Limentani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Hawthorne Ln
Fl 3
Charlotte, NC 28204Phone+1 704-384-9234Fax+1 704-417-4400
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1989 - 1992
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1986 - 1989
Tufts University School of MedicineClass of 1986
Certifications & Licensure
NC State Medical License 1995 - 2025
MA State Medical License 1988 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- America's Top Doctors for Cancer Castle Connolly, 2007-2013
- Charlotte Magazine Castle Connolly, 2005
- Join now to see all
Clinical Trials
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Publications & Presentations
PubMed
- 521 citationsPhase II Study of the Antibody Drug Conjugate Trastuzumab-DM1 for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2) –Positive Breast Cancer After Prior ...Howard A. Burris, Hope S. Rugo, Svetislava J. Vukelja, Charles L. Vogel, Rachel A. Borson
Journal of Clinical Oncology. 2011-02-01 - 14 citationsAdjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE.Sibylle Loibl, Chiun-Sheng Huang, Max S Mano, Eleftherios P Mamounas, Charles E Geyer Jr
NPJ Breast Cancer. 2022-09-19 - 39 citationsTrebananib (AMG 386) plus weekly paclitaxel with or without bevacizumab as first-line therapy for HER2-negative locally recurrent or metastatic breast cancer: A phase ...Véronique Diéras, Hans Wildiers, Jacek Jassem, Luc Dirix, Jean-Paul Guastalla
Breast. 2015-06-01
Press Mentions
Novant Health Rebrands Cancer Care to Show a Comprehensive Approach in a Growing SectorSeptember 2nd, 2020
Novant Health Announces New Leader in Cancer ServicesJanuary 18th, 2017
Grant Support
- GLA Domain In Blood Clotting ProteinsNational Heart, Lung, And Blood Institute1990–1994
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
